XML 60 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Licensing and Commercialization Agreement (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended 22 Months Ended
Jun. 30, 2018
Aug. 31, 2017
Jul. 31, 2017
Jun. 30, 2016
Mar. 31, 2015
Sep. 30, 2014
May 31, 2014
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Jun. 30, 2016
Agreement                                      
Upfront fees received   $ 16,900                                  
Total collaboration revenue               $ 0 $ 0 $ 0 $ 0 $ 0 $ 206,654 $ 1,661 $ 1,662 $ 0 $ 209,977 $ 50,909  
License revenue                                      
Agreement                                      
Total collaboration revenue                               0 152,912 22,937  
Research and development activity revenue                                      
Agreement                                      
Total collaboration revenue                               0 56,180 9,741  
API transfer revenue                                      
Agreement                                      
Total collaboration revenue                               0 754 18,212  
Joint operating committee revenue                                      
Agreement                                      
Total collaboration revenue                               $ 0 $ 131 $ 19  
Licensing and Commercialization Agreement | Novartis Pharma AG                                      
Agreement                                      
Upfront fees received     $ 189,800       $ 200,000                        
Total collaboration revenue                         $ 206,700            
Licensing and Commercialization Agreement | Novartis Pharma AG | Achievement of specified patient enrollment milestones                                      
Agreement                                      
Patient enrollment-based milestone revenue achieved       $ 30,000 $ 50,000 $ 50,000                         $ 130,000
Research and development | RHO-adRP License Agreement | University of Florida Research Foundation (UFRF)                                      
Agreement                                      
Payments for license fees $ 500                                    
Research and development | RHO-adRP License Agreement | University of Florida Research Foundation (UFRF) | Specified Clinical, Marketing Approval and Reimbursement Approval Milestones Related to a Licensed Product                                      
Agreement                                      
Payments for license fees 23,500                                    
Research and development | RHO-adRP License Agreement | University of Florida Research Foundation (UFRF) | Specified Commercial Sales Milestones Related to a Licensed Product                                      
Agreement                                      
Payments for license fees 70,000                                    
General and administrative | RHO-adRP License Agreement | University of Florida Research Foundation (UFRF)                                      
Agreement                                      
Payments for license fees $ 30